AviadoBio broadens vMiX gene silencing licence with King’s College London
AviadoBio has extended its exclusive licence agreement with King’s College London to apply the vMiX RNAi gene-silencing platform across all human therapeutic areas.
Read the full article on the original site.
Read Full Article